Showing results (201-210 of 219) with videos related to
Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2022
Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study)Takeshi Arashiro, Yuzo Arima, Hirokazu Muraoka, et al.Journal of Epidemiology|February 9, 2025
Post COVID-19 condition in hospitalized survivors after one year of infection during the Alpha- and Delta-variant dominant waves in Japan: COVID-19 Recovery Study IIYoko Muto, Mariko Hosozawa, Miyuki Hori, et al.Iscience|July 14, 2023
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccinationShinya Yamamoto, Seiya Yamayoshi, Mutsumi Ito, et al.Emerging Infectious Diseases|October 5, 2022
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Moe Okuda, et al.Journal of Medical Microbiology|August 5, 2015
Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?Mitsutoshi Senoh, Haru Kato, Tadashi Fukuda, et al.Jac-Antimicrobial Resistance|March 7, 2025
Molecular epidemiology and patient outcome of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research networkSho Saito, Aki Sakurai, Yasufumi Matsumura, et al.Critical Care Explorations|July 21, 2026
Social Determinants of Health and Long‑Term Joblessness Among Severe COVID‑19 Survivors: Secondary Analysis of a Nationwide 2‑Year Prospective Cohort (COVID-19 Recovery Study II)Akira Kawauchi, Mitsunobu Nakamura, Shuhei Maruyama, et al.Open Forum Infectious Diseases|June 23, 2023
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in JapanTakeshi Arashiro, Yuzo Arima, Jin Kuramochi, et al.Journal of Global Antimicrobial Resistance|April 16, 2022
Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in JapanKeisuke Oka, Akane Matsumoto, Nobuyuki Tetsuka, et al.Eclinicalmedicine|February 16, 2021
Antibody titers against SARS-CoV-2 decline, but do not disappear for several monthsSeiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, et al.Pageof 22